Replies to post #5028 on Ayala Pharmaceuticals Inc (ADXS)

[shub]

It's also possible that there is some negative PR yet to be released and we are getting while the getting is good. To be expected sooner or later.
We should be setting up and funding clinical trials on all our solid constructs ASAP. That should have happened years ago.
Clinical trials are extremely expensive, but if successful, increase our value and bargaining position dramatically. Recently read that clinical trials for a cancer drug runs about 300 million bucks. We can't even fund one yet.
Once we get a successful drug or 2 on the market, then we can fund the rest.

Meanwhile, other companies and researchers are working furiously on the same problems with advanced techniques, knowledge and instrumentation, and our big lead is fast vanishing.